SBC Medical Group Holdings Incorporated (SBC) Stock Analysis

SBC is an asset-light medical-services platform that provides affiliated and independent clinics with non-clinical infrastructure, including marketing, recruitment, procurement, equipment rental, real estate, CRM, booking software, and loyalty programs. Originally founded as Shonan Beauty Clinic in 2000, it has evolved into a scalable support network with 287 locations and more than 6.9 million annual visits, primarily in Japan but increasingly in Thailand, Singapore, and the United States. **Q2 2026 demonstrated a sharp earnings recovery:** revenue rose 13.4% year over year to $49.19 million, net income increased 334.6% to $10.69 million, and Adjusted EBITDA rose 31.4% to $20.09 million, producing a 40.8% margin. EPS of $0.10 missed the $0.12 estimate, but revenue exceeded consensus by 8.2%. **Valuation remains depressed at roughly 8.1x–8.4x trailing P/E and 3.9x EV/EBITDA**, despite a reported 22% net margin, $184.3 million cash balance, and only $37.75 million of debt. Near-term catalysts include the $15 million annualized service-fee opportunity, full realization expected in fiscal 2027, AI call-center efficiencies, Waqoo growth, and international expansion. The principal offset is approximately 89% related-party revenue concentration and JPY translation risk.